Webinar
Select IP with Hogan Lovells | Webinar no. 19: Cross-over topics: Patent & regulatory topics I
22 March 2023 | 3:00 PM - 4:30 PM (JST)
PartnerBoston
Email [email protected]hoganlovells.com
Phone +1 617 371 1003
Fax +1 617 371 1037
Practice groupIntellectual Property, Media, and Technology
Kristin A. Connarn leverages her background in biotechnology and cancer research to effectively guide clients through strategic patent portfolio development and management. Her practice focuses on life sciences patent prosecution, portfolio development, and management in the biotechnology and pharmaceutical sectors.
Kristin's clients range from startups to international pharmaceutical companies, nonprofits, medical centers, and universities, as well as venture capital and private equity investors. She supports clients in strategic counseling, patent portfolio development and management, and patent prosecution. She also guides clients through transactions and agreements that involve intellectual property assets, including joint development agreements, sponsored research agreements, licenses, and complex commercial transactions.
Kristin has vast experience working with companies developing novel biologics in the cell and gene therapy spaces, including oncology, autoimmune, and inflammatory diseases. She assists clients in developing and executing IP protection strategies on therapeutic antibodies, recombinant proteins, targeted delivery of therapeutic including using antibodies and nanoparticles, and therapies including microbiome transplantations, CAR-T, CAR-NK, and TCR-T cells. Kristin also works with companies developing biologics to treat and prevent infections, including COVID-19.
Kristin's patent prosecution experience includes methods of treatment and diagnostics, dry powder inhalation therapies, food science, vaccines, and medical devices. She develops and delivers trainings for in-house legal and scientific teams regarding invention disclosures, patentability, and inventorship.
Kristin has industry experience as a researcher for the Cancer Bioscience and CNS groups at AstraZeneca R&D Boston, where she applied molecular and cell biology techniques to research cancer and Alzheimer's disease. She also researched gene activation with Transkaryotic Therapies.
Patent Law
Best Lawyers in America
Patents: Prosecution
Legal 500 US
Ranked in U.S. (Massachusetts)
IAM Patent 1000
Boston Rising Star
The National Law Journal
Education
J.D., Suffolk University Law School, cum laude, 2005
B.S. Biotechnology, Worcester Polytechnic Institute, with high distinction, 1999
Bar admissions and qualifications
Massachusetts
New Hampshire
Webinar
22 March 2023 | 3:00 PM - 4:30 PM (JST)
Webinar
04 April 2023 | 12:00 PM - 1:00 PM (ET)
News
06 December 2022
News
04 November 2022
Awards and Rankings
13 June 2022
Sponsorships and Speaking Engagements
22 December 2021